login
Rusotinib Transplant anti-host disease European Medicines Agency European Union gvhd treat
04-01
New crown pneumonia omicron European Medicines Agency marco knights
01-12
![Alerts! Rusotinib receives EU recommended approval for the treatment of acute or chronic graft-versus-host disease[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
